Vaxart, Inc.
(NASDAQ : VXRT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.45%160.070.0%$1484.90m
NVAXNovavax, Inc. -6.32%84.6578.2%$581.13m
AMGNAmgen, Inc. -0.52%227.721.4%$512.75m
BIIBBiogen, Inc. -2.39%220.521.8%$496.77m
GILDGilead Sciences, Inc. 1.03%68.511.0%$492.03m
BNTXBioNTech SE -5.77%147.500.0%$413.51m
REGNRegeneron Pharmaceuticals, Inc. 1.14%621.402.7%$402.73m
ILMNIllumina, Inc. -3.81%365.943.3%$378.85m
VRTXVertex Pharmaceuticals, Inc. -0.23%228.081.9%$340.95m
SNSSSunesis Pharmaceuticals, Inc. -3.99%2.650.7%$185.24m
EXASEXACT Sciences Corp. -2.63%74.0317.9%$168.66m
ARNAArena Pharmaceuticals, Inc. -0.58%90.4813.7%$131.37m
INCYIncyte Corp. 0.04%74.792.4%$130.18m
ALNYAlnylam Pharmaceuticals, Inc. -1.37%136.418.2%$125.00m
BMRNBioMarin Pharmaceutical, Inc. 0.24%84.654.2%$103.18m

Company Profile

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.